𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Adalimumab, a Tumor Necrosis Factor Blockade Therapy, Decreases Th1 and Th17 Populations in Rheumatoid Arthritis Patients

✍ Scribed by Barbara Pesce; Diego Catalan; Natalia Orrego; Octavio Aravena; Lilian Soto; Pamela Wurman; Francisca Sabugo; Miguel Cuchacovich; Juan Aguillon


Book ID
113541722
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
43 KB
Volume
135
Category
Article
ISSN
1090-2341

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES